These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35231899)

  • 21. Traumatic brain injury and intracranial hemorrhage-induced cerebral vasospasm: a systematic review.
    Al-Mufti F; Amuluru K; Changa A; Lander M; Patel N; Wajswol E; Al-Marsoummi S; Alzubaidi B; Singh IP; Nuoman R; Gandhi C
    Neurosurg Focus; 2017 Nov; 43(5):E14. PubMed ID: 29088959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis.
    Grossen AA; Ernst GL; Bauer AM
    Neurosurg Focus; 2022 Mar; 52(3):E10. PubMed ID: 35231885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin infusions in aneurysmal subarachnoid hemorrhages: clinical considerations for use beyond anticoagulation.
    Kormanyos Z; Reinert JP; Brady P
    Expert Rev Clin Pharmacol; 2022 Dec; 15(12):1415-1421. PubMed ID: 36377793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.
    Ditz C; Machner B; Schacht H; Neumann A; Schramm P; Tronnier VM; Küchler J
    Neurosurg Rev; 2021 Oct; 44(5):2899-2912. PubMed ID: 33492514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
    Wang X; Li YM; Li WQ; Huang CG; Lu YC; Hou LJ
    PLoS One; 2012; 7(10):e47778. PubMed ID: 23082215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of early stellate ganglion block in cerebral vasospasm after aneurysmal subarachnoid hemorrhage (BLOCK-CVS): study protocol for a randomized controlled trial.
    Jing L; Wu Y; Liang F; Jian M; Bai Y; Wang Y; Liu H; Wang A; Chen X; Han R
    Trials; 2022 Nov; 23(1):922. PubMed ID: 36333751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Zhu Y; Jiang H; Li Y; Weng Y; Xu K; Zhou L; Lin H; Sun T; Cheng D; Shen J; Zeng J; Ye D; Wang D; Zhan R
    Neurocrit Care; 2019 Dec; 31(3):466-475. PubMed ID: 31016639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
    Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
    J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultra-Early Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
    Phan K; Moore JM; Griessenauer CJ; Xu J; Teng I; Dmytriw AA; Chiu AH; Ogilvy CS; Thomas A
    World Neurosurg; 2017 Jun; 102():632-638.e1. PubMed ID: 28365434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2021 Aug; 22(12):1601-1614. PubMed ID: 33823726
    [No Abstract]   [Full Text] [Related]  

  • 32. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    Dayyani M; Sadeghirad B; Grotta JC; Zabihyan S; Ahmadvand S; Wang Y; Guyatt GH; Amin-Hanjani S
    Stroke; 2022 Jun; 53(6):1993-2005. PubMed ID: 35354302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
    Romero Kräuchi O; Verger Bennasar AM
    Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
    Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cilostazol treatment for patients with aneurysmal subarachnoid hemorrhage: A meta-analysis of 14 studies.
    Li L; Fu X; Qiu H; Shi P
    J Clin Neurosci; 2022 May; 99():190-203. PubMed ID: 35286971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?
    Croci DM; Dalolio M; Aghlmandi S; Taub E; Rychen J; Chiappini A; Zumofen D; Guzman R; Mariani L; Roethlisberger M
    Neurol Res; 2021 Jan; 43(1):40-53. PubMed ID: 33106124
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacologic Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
    Smetana KS; Buschur PL; Owusu-Guha J; May CC
    Crit Care Nurs Q; 2020; 43(2):138-156. PubMed ID: 32084059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigational drugs for vasospasm after subarachnoid hemorrhage.
    Tallarico RT; Pizzi MA; Freeman WD
    Expert Opin Investig Drugs; 2018 Apr; 27(4):313-324. PubMed ID: 29600883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.